|
EXP002268
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
MGPE9
|
miRNA mimic
|
yes |
no |
|
no |
no |
|
EXP002269
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
sMGPE9
|
miRNA mimic
|
yes |
yes |
|
no |
no |
|
EXP002270
|
NickFect type of cell-penetrating peptides present enhanced efficiency for micr…
|
2020 |
NF71
|
miRNA mimic
|
yes |
|
yes |
yes |
yes |
|
EXP002271
|
Cell-Selective Delivery of MicroRNA with a MicroRNA–Peptide Conjugate Nanocompl…
|
2018 |
c(RGDfK)-R9
|
miRNA mimic
|
yes |
yes |
|
no |
no |
|
EXP002272
|
Cell-Selective Delivery of MicroRNA with a MicroRNA–Peptide Conjugate Nanocompl…
|
2018 |
FA-R9
|
miRNA mimic
|
yes |
yes |
|
no |
no |
|
EXP002273
|
Control of cancer stem cell like population by intracellular target identificat…
|
2017 |
LMWP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002274
|
Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide…
|
2006 |
Tat(48–57)
|
2-5A (oligoadenylate)
|
yes |
yes |
yes |
no |
no |
|
EXP002275
|
Comparison of Nanomaterials for Delivery of Double-Stranded RNA in Caenorhabdit…
|
2020 |
poly-L-arginine (PLR)
|
dsRNA
|
no |
|
no |
yes |
no |
|
EXP002276
|
Comparison of Nanomaterials for Delivery of Double-Stranded RNA in Caenorhabdit…
|
2020 |
poly-L-lysine (PLK)
|
dsRNA
|
no |
|
no |
yes |
no |
|
EXP002277
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002278
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002279
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP3
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002280
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002281
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002282
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP6
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002283
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP7
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002284
|
Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors
|
2019 |
LP8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002285
|
Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression
|
2021 |
PDL1-CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002286
|
Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression
|
2021 |
PDL1-CPP
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002287
|
Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery…
|
2011 |
TAT (± RGD4C)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002288
|
Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery…
|
2011 |
TAT + RGD4C
|
siRNA
|
yes |
|
yes |
yes |
no |
|
EXP002289
|
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblasto…
|
2020 |
iRGD
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002290
|
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblasto…
|
2020 |
iRGD
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002291
|
Cell-penetrating peptide conjugates of peptide nucleic acids as inhibitors of H…
|
2005 |
Tat
|
PNA (antisense analogue)
|
yes |
yes |
yes |
no |
no |
|
EXP002292
|
Cell-penetrating peptide conjugates of peptide nucleic acids as inhibitors of H…
|
2005 |
Transportan
|
PNA (antisense analogue)
|
yes |
yes |
yes |
no |
no |
|
EXP002293
|
Cell-penetrating peptide conjugates of peptide nucleic acids as inhibitors of H…
|
2005 |
R6-Penetratin
|
PNA (antisense analogue)
|
yes |
yes |
yes |
no |
no |
|
EXP002294
|
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA deli…
|
2013 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002295
|
Systemic peptide-mediated oligonucleotide therapy improves long-term survival i…
|
2016 |
Pip6a
|
PMO (splice-switching antisense oligonucleotide)
|
yes |
yes |
|
no |
no |
|
EXP002296
|
Systemic peptide-mediated oligonucleotide therapy improves long-term survival i…
|
2016 |
Pip6a
|
PMO (splice-switching antisense oligonucleotide)
|
yes |
|
|
yes |
yes |
|
EXP002297
|
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficien…
|
2006 |
(R-Ahx-R)4
|
PMO (morpholino)
|
yes |
yes |
|
no |
no |
|
EXP002298
|
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficien…
|
2006 |
Tat(48–60)
|
PMO (morpholino)
|
yes |
yes |
|
no |
no |
|
EXP002299
|
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficien…
|
2006 |
R9F2
|
PMO (morpholino)
|
yes |
yes |
|
no |
no |
|
EXP002300
|
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Oc…
|
2008 |
POD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002301
|
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Oc…
|
2008 |
POD
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP002302
|
Cell-penetrating Peptide for Enhanced Delivery of Nucleic Acids and Drugs to Oc…
|
2008 |
POD
|
|
yes |
|
|
yes |
no |
|
EXP002303
|
Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Ass…
|
2019 |
Chol-R9
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002304
|
Reshaping Prostate Tumor Microenvironment To Suppress Metastasis via Cancer-Ass…
|
2019 |
Chol-R9
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002305
|
Prolongation of Life in Rats with Malignant Glioma by Intranasal siRNA/Drug Cod…
|
2014 |
Tat-modified MPEG-PCL
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002306
|
Prolongation of Life in Rats with Malignant Glioma by Intranasal siRNA/Drug Cod…
|
2014 |
Tat-modified MPEG-PCL
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002307
|
Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi an…
|
2017 |
TCPA2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002308
|
Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi an…
|
2017 |
TCPA2
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002309
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
GYR
|
|
no |
no |
|
no |
no |
|
EXP002310
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002311
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002312
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002313
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002314
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY-(K)-FAM
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002315
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
CGY-(K)-FAM
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002316
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-GYR
|
|
no |
no |
|
no |
no |
|
EXP002317
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP1
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002318
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP1
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002319
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP2
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002320
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
FAM-CGY-SP2
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002321
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002322
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002323
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY-SP1
|
siRNA
|
no |
yes |
yes |
yes |
no |
|
EXP002324
|
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled f…
|
2019 |
Cy5.5-CGY-SP1
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002325
|
siRNA and pharmacological inhibition of endocytic pathways to characterize the …
|
2012 |
R8
|
|
yes |
no |
|
no |
no |
|
EXP002326
|
siRNA and pharmacological inhibition of endocytic pathways to characterize the …
|
2012 |
HIV-Tat
|
|
yes |
no |
|
no |
no |
|
EXP002327
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF14
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP002328
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF14
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002329
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF14
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002330
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF221
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP002331
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF221
|
SCO
|
yes |
yes |
|
no |
no |
|
EXP002332
|
Graphene oxide nanosheets in complex with cell penetrating peptides for oligonu…
|
2017 |
PF221
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002333
|
Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with seq…
|
2019 |
R8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002334
|
Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with seq…
|
2019 |
R8
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002335
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
MPGDNLS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002336
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
CADY
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002337
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
MPGDNLS
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002338
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
CADY
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002339
|
Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-…
|
2016 |
TATp
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002340
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
DP7-C
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002341
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
DP7-C
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002342
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
TAT-C
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002343
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
TAT-C
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002344
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
R9-C
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002345
|
Hyaluronic acid-modified cholesterol-conjugated cell-penetrating peptides for n…
|
2021 |
R9-C
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002346
|
Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA na…
|
2018 |
R8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002347
|
Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA na…
|
2018 |
R8
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002348
|
Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-p…
|
2012 |
Tat-CG analog
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002349
|
Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-p…
|
2012 |
Tat-CG analog
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002350
|
Novel miR-122 delivery system based on MS2 virus like particle surface displayi…
|
2016 |
HIV-Tat (47–57)
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002351
|
Novel miR-122 delivery system based on MS2 virus like particle surface displayi…
|
2016 |
HIV-Tat (47–57)
|
miRNA
|
yes |
|
|
yes |
yes |
|
EXP002352
|
Stealth and Fully-Laden Drug Carriers: Self-Assembled Nanogels Encapsulated wit…
|
2018 |
tumor-homing CPP (PEGA-pVEC)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002353
|
Stealth and Fully-Laden Drug Carriers: Self-Assembled Nanogels Encapsulated wit…
|
2018 |
tumor-homing CPP (PEGA-pVEC)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002354
|
Systemic delivery of a peptide-linked morpholino oligonucleotide neutralizes mu…
|
2013 |
Peptide B
|
antisense morpholino (PPMO)
|
no |
|
|
yes |
yes |
|
EXP002355
|
Systemic delivery of a peptide-linked morpholino oligonucleotide neutralizes mu…
|
2013 |
Peptide K
|
antisense morpholino (PPMO)
|
no |
|
|
yes |
yes |
|
EXP002356
|
Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridizat…
|
2004 |
Transportan (TP)
|
dsDNA transcription factor decoy
|
yes |
yes |
|
no |
no |
|
EXP002357
|
Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridizat…
|
2004 |
Transportan-10 (TP10)
|
dsDNA transcription factor decoy
|
yes |
yes |
|
no |
no |
|
EXP002358
|
Multistage pH-responsive codelivery liposomal platform for synergistic cancer t…
|
2022 |
DPRP (dual pH-responsive peptide)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002359
|
Multistage pH-responsive codelivery liposomal platform for synergistic cancer t…
|
2022 |
DPRP (dual pH-responsive peptide)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002360
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
D4F
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002361
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
D4F
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP002362
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
tLyP-1
|
|
no |
|
|
no |
no |
|
EXP002363
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
tLyP-1-D4F
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002364
|
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration deliver…
|
2022 |
tLyP-1-D4F
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002365
|
Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient…
|
2021 |
cRGD-R9
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002366
|
Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient…
|
2021 |
cRGD-R9
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002367
|
Cyclic Peptide-Capped Gold Nanoparticles for Enhanced siRNA Delivery
|
2014 |
WR5
|
siRNA
|
yes |
no |
|
no |
no |